These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7910774)

  • 1. Medication effects on referent communication in schizophrenic patients: an evaluation with a structured task.
    Clark A; Harvey P; Alpert M
    Brain Lang; 1994 Apr; 46(3):392-401. PubMed ID: 7910774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formal thought disorders: French translation of the Thought, Language and Communication assessment scale].
    Bazin N; Lefrere F; Passerieux C; Sarfati Y; Hardy-Baylé MC
    Encephale; 2002; 28(2):109-19. PubMed ID: 11972137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversational repair in schizophrenic and normal children.
    Caplan R; Guthrie D; Komo S
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):950-8. PubMed ID: 8768357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental psychological studies of speech disorders in schizophrenic patients: problems and methods (a review)].
    Kritskaia VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(1):119-23. PubMed ID: 6986727
    [No Abstract]   [Full Text] [Related]  

  • 5. Disordered verbalizations in schizophrenia: a speech disturbance or thought disorder?
    Harrow M; O'Connell EM; Herbener ES; Altman AM; Kaplan KJ; Jobe TH
    Compr Psychiatry; 2003; 44(5):353-9. PubMed ID: 14505295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
    Nagase Y; Okubo Y; Toru M
    Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antipsychotic medication on the linguistic ability of schizophrenics.
    Hymowitz P; Spohn H
    J Nerv Ment Dis; 1980 May; 168(5):287-96. PubMed ID: 6102593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptomatology of speech disorders in schizophrenia in the light of modern research. II].
    Rogovin MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(1):141-6. PubMed ID: 4466224
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia.
    Hutton SB; Crawford TJ; Gibbins H; Cuthbert I; Barnes TR; Kennard C; Joyce EM
    Psychopharmacology (Berl); 2001 Sep; 157(3):284-91. PubMed ID: 11605084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cognitive origins of specific types of schizophrenic speech disturbances.
    Docherty NM; Strauss ME; Dinzeo TJ; St-Hilaire A
    Am J Psychiatry; 2006 Dec; 163(12):2111-8. PubMed ID: 17151162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of communication of schizophrenic, neurotic, and healthy adolescents].
    Wiemer P; Bunk D; Eggers C
    Prax Kinderpsychol Kinderpsychiatr; 2001 Jan; 50(1):16-30. PubMed ID: 11233570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
    Hornung WP; Schonauer K; Feldmann R; Mönking HS
    Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia and language disorders].
    Barrelet L; Piguet D; Corradini S
    Encephale; 1993; 19(5):533-40. PubMed ID: 8306921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation sensitivity as a moderator of communication disorder in schizophrenia.
    Grant PM; Beck AT
    Psychol Med; 2009 Jul; 39(7):1211-9. PubMed ID: 19379529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.